News
![Navidea Biopharmaceuticals Appoints Joshua Wilson to the Board of Directors; Announces Dates Related to its 2022 Annual Meeting of Stockholders: https://mms.businesswire.com/media/20191107006076/en/389794/5/navidea_cmyk.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNllsRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--8f98c3cfd17bc93aed823f932a665c78f3f036eb/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/navidea_cmyk.jpg?locale=us)
Navidea Biopharmaceuticals Appoints Joshua Wilson to the Board of Directors; Announces Dates Related to its 2022 Annual Meeting of Stockholders
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today
![Renewi plc: Block listing Interim Review](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Renewi plc: Block listing Interim Review
![PhosAgro PJSC: PhosAgro Board of Directors to Elect New Chairman on October 3](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
PhosAgro PJSC: PhosAgro Board of Directors to Elect New Chairman on October 3
![Form 8.3 - Maitland Institutional Services Limited: Re Attraqt Group plc](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
Form 8.3 - Maitland Institutional Services Limited: Re Attraqt Group plc
![Form 8.3 - Maitland Institutional Services Limited: Re RPS Group plc](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Form 8.3 - Maitland Institutional Services Limited: Re RPS Group plc
![UiPath Recognizes Global Winners of 2022 Partner Awards at FORWARD 5 Conference: https://mms.businesswire.com/media/20210427005075/en/718791/5/new_uipath_logo_orange.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBemR1Vmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--50f843081684f238e6dd1d51a03e004067551830/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/new_uipath_logo_orange.jpg?locale=us)
UiPath Recognizes Global Winners of 2022 Partner Awards at FORWARD 5 Conference
UiPath (NYSE: PATH), a leading enterprise automation software company, today at its global user conference, FORWARD 5, announced the winners of the UiPath 2022 Partner Awards. The awards celebrate
![IMV Provides an Update on The VITALIZE Trial: https://mms.businesswire.com/media/20200225005324/en/775456/5/IMV_Logos_IMV-Logo_BrandStatement.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBenlNSlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--44b7c2e9ec1d34b6817ce17f4c733565e4a558a7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/IMV_Logos_IMV-Logo_BrandStatement.jpg?locale=us)
IMV Provides an Update on The VITALIZE Trial
IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company developing a portfolio of immune-educating therapies based on its novel DPX® platform to treat solid and hematologic
![Chelverton UK Dividend Trust plc: Net Asset Value(s)](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
![EQS-Adhoc: ALLGEIER SE: Georg Dürschmidt takes over as Chairman of the Supervisory Board of Allgeier SE](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
EQS-Adhoc: ALLGEIER SE: Georg Dürschmidt takes over as Chairman of the Supervisory Board of Allgeier SE
![Form 8.3 - The Vanguard Group, Inc.: Tullow Oil plc](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
Form 8.3 - The Vanguard Group, Inc.: Tullow Oil plc
![Fix Price Group PLC: Notification of PDMR transaction](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Fix Price Group PLC: Notification of PDMR transaction
![Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
![Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc
![Superdry plc: Total Voting Rights](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Superdry plc: Total Voting Rights
![Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
![Form 8.3 - The Vanguard Group, Inc.: HomeServe plc](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
![Form 8.3 - The Vanguard Group, Inc.: Capricorn Energy plc](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Form 8.3 - The Vanguard Group, Inc.: Capricorn Energy plc
![Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
![Form 8.3 - The Vanguard Group, Inc.: AVEVA Group plc](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
Form 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
![Convatec Group PLC: Director/ PDMR Shareholding](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
Convatec Group PLC: Director/ PDMR Shareholding
![EQS-News: Advanced Blockchain AG publishes half-year figures](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
EQS-News: Advanced Blockchain AG publishes half-year figures
![EQS-News: Compleo Charging Solutions AG: Compleo realigns production](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
EQS-News: Compleo Charging Solutions AG: Compleo realigns production
![Chelverton UK Dividend Trust plc: Monthly Factsheet](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
Chelverton UK Dividend Trust plc: Monthly Factsheet
![Rights and Issues Investment Trust PLC: Net Asset Value(s)](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
![EQS-News: MEDIQON Group AG: Interim Report 2022 – Positive development of the group in the first half of 2022](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)